FDA Clearance Tracker · P100049-S037
LINX Reflux Management System
Last checked: Nov 20, 2026Latest source record: Feb 22, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Feb 22, 2024
Approved
Time to decision
87 days
Received Nov 27, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P100049-S037
- Device name
- LINX Reflux Management System
- Applicant
- Torax Medical
- Applicant location
- Cincinnati, OH
- Received
- Nov 27, 2023
- Decided
- Feb 22, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P100049
Device type
- Device type
- IMPLANT, ANTI-GASTROESOPHAGEAL REFLUX (LEI)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE FOLLOWING LABELING UPDATES:1) Removal of Barrett's Esophagus (BE) from a precaution statement in the instructions for use. LINX has not been demonstrated to be an effective treatment that leads to BE regression or prevention of progression to cancer. As such, patients with BE who are treated with LINX for management of GERD symptoms should consult with their physician for continued treatment of BE (including PPI use).2) Addition of a "Clinical Data Summary" section that describes a single observational study that supports safe use of the LINX device to treat GERD symptoms in patients with known BE3) Updates to the Patient Information Booklet to align with changes to the instructions for use.
Source documents
Other decisions for Torax Medical
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K230089 · Decided Feb 9, 2023 · 28 days after receipt
Device type: Laparoscopic Accessories, Esophageal Sizing (QJN) · GI, Urology & Nephrology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.